Biovista

Biovista specializes in providing services to the biopharmaceutical sector, including drug repositioning, mitigating drug risks, and addressing clinical holds. Leveraging artificial intelligence (AI), they focus on developing a portfolio of repurposed drug candidates targeting various medical conditions, including epilepsy, oncology, neurodegenerative diseases, and rare disorders.